Postbiotics Market Projected to Reach $235.9 Million by 2031

The global postbiotics market is projected to expand from an estimated $150 million in 2026 to $235.9 million by 2031, demonstrating a compound annual growth rate of 9.5%, according to a new report by Wissen Research.

Postbiotics, defined as preparations of inactive microorganisms or their components offering health benefits, offer a significant advantage due to their stability at room temperature. This characteristic allows for the development of ambient products, such as supplements, snack bars, and beverages, without the need for a cold chain, unlike products relying on live probiotics.

Key drivers for this market expansion include the inherent shelf-stability of postbiotics, a more standardized scientific definition established in 2021, and growing research into the systemic effects of short-chain fatty acids. Emerging opportunities in companion nutrition for GLP-1 weight loss medications, as well as applications in pet food and personal care, are also contributing to growth.

Despite the positive outlook, the industry faces challenges including the lack of a harmonized global regulatory framework and difficulties in analytical standardization. Recent developments include The Akkermansia Company's launch of METAbiotics for metabolic health and Superbrewed Food's introduction of Thryvia for digestive and immune support.